Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year”

Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens

May 8

Written by Van Agens

Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis

Longhorn Vaccines and Diagnostics Presents Compelling Data on LHNVD-303 Vaccine for Sepsis Related to Bacterial Infections at the World Vaccine Congress